Pill

Hims & Hers announced Saturday that it would stop selling what it claims is a cheaper, compounded version of Novo Nordisk’s obesity pill on its telehealth platform, after health officials called for an investigation into the company for potential violations of federal law. Hims launched the compounded drug earlier this week at $49 per month. […]